Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
Versteijne E, de Hingh IHJT, Homs MYV, Intven MPW, Klaase JM, van Santvoort HC, de Vos-Geelen J, Wilmink JW, van Tienhoven G. Versteijne E, et al. Among authors: van santvoort hc, van tienhoven g. Front Oncol. 2022 Feb 14;11:744161. doi: 10.3389/fonc.2021.744161. eCollection 2021. Front Oncol. 2022. PMID: 35237500 Free PMC article. Review.
Feasibility and repeatability of PET with the hypoxia tracer [(18)F]HX4 in oesophageal and pancreatic cancer.
Klaassen R, Bennink RJ, van Tienhoven G, Bijlsma MF, Besselink MG, van Berge Henegouwen MI, Wilmink JW, Nederveen AJ, Windhorst AD, Hulshof MC, van Laarhoven HW. Klaassen R, et al. Among authors: van laarhoven hw, van tienhoven g, van berge henegouwen mi. Radiother Oncol. 2015 Jul;116(1):94-9. doi: 10.1016/j.radonc.2015.05.009. Epub 2015 Jun 3. Radiother Oncol. 2015. PMID: 26049919 Free article.
Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-Based Chemoradiation in Locally Advanced Pancreatic Cancer.
van Zweeden AA, van der Vliet HJ, Wilmink JW, Meijerink MR, Meijer OW, Bruynzeel AM, van Tienhoven G, Giovannetti E, Kazemier G, Jacobs MA, Verheul HM. van Zweeden AA, et al. Among authors: van der vliet hj, van tienhoven g. Clin Cancer Res. 2015 Oct 15;21(20):4569-75. doi: 10.1158/1078-0432.CCR-14-3364. Epub 2015 Jun 8. Clin Cancer Res. 2015. PMID: 26056353 Clinical Trial.
Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial.
Versteijne E, van Eijck CH, Punt CJ, Suker M, Zwinderman AH, Dohmen MA, Groothuis KB, Busch OR, Besselink MG, de Hingh IH, Ten Tije AJ, Patijn GA, Bonsing BA, de Vos-Geelen J, Klaase JM, Festen S, Boerma D, Erdmann JI, Molenaar IQ, van der Harst E, van der Kolk MB, Rasch CR, van Tienhoven G; Dutch Pancreatic Cancer Group (DPCG). Versteijne E, et al. Among authors: van der kolk mb, van eijck ch, van der harst e, van tienhoven g. Trials. 2016 Mar 9;17(1):127. doi: 10.1186/s13063-016-1262-z. Trials. 2016. PMID: 26955809 Free PMC article. Clinical Trial.
Considerable pancreatic tumor motion during breath-holding.
Lens E, van der Horst A, Versteijne E, Bel A, van Tienhoven G. Lens E, et al. Among authors: van der horst a, van tienhoven g. Acta Oncol. 2016 Nov;55(11):1360-1368. doi: 10.1080/0284186X.2016.1221532. Epub 2016 Sep 1. Acta Oncol. 2016. PMID: 27583771 Clinical Trial.
Considerable interobserver variation in delineation of pancreatic cancer on 3DCT and 4DCT: a multi-institutional study.
Versteijne E, Gurney-Champion OJ, van der Horst A, Lens E, Kolff MW, Buijsen J, Ebrahimi G, Neelis KJ, Rasch CR, Stoker J, van Herk M, Bel A, van Tienhoven G. Versteijne E, et al. Among authors: van der horst a, van tienhoven g, van herk m. Radiat Oncol. 2017 Mar 23;12(1):58. doi: 10.1186/s13014-017-0777-0. Radiat Oncol. 2017. PMID: 28335780 Free PMC article. Clinical Trial.
Addition of MRI for CT-based pancreatic tumor delineation: a feasibility study.
Gurney-Champion OJ, Versteijne E, van der Horst A, Lens E, Rütten H, Heerkens HD, Paardekooper GMRM, Berbee M, Rasch CRN, Stoker J, Engelbrecht MRW, van Herk M, Nederveen AJ, Klaassen R, van Laarhoven HWM, van Tienhoven G, Bel A. Gurney-Champion OJ, et al. Among authors: van laarhoven hwm, van der horst a, van tienhoven g, van herk m. Acta Oncol. 2017 Jul;56(7):923-930. doi: 10.1080/0284186X.2017.1304654. Epub 2017 Apr 4. Acta Oncol. 2017. PMID: 28375667
195 results